MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer

References

• Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008 May;83(5):584–594. PubMed PMID: 18452692; PubMed Central PMCID: PMCPMC2718421.
   PubMed Web of Science ®Google Scholar
• Huber RM. Is lung cancer in never-smokers a different disease?–back to the figures. J Thorac Oncol. 2007 Sep;2(9):787–788. PubMed PMID: 17805053.
   PubMed Web of Science ®Google Scholar
• Mehta A, Dobersch S, Romero-Olmedo AJ, et al. Epigenetics in lung cancer diagnosis and therapy. Cancer Metastasis Rev. 2015 Jun;34(2):229–241. PubMed PMID: 25939322.
   PubMed Web of Science ®Google Scholar
• Gridelli C, Rossi A, Carbone DP, et al. Non-small-cell lung cancer [Primer]. Nat Rev Dis Primers. 2015 05/21/online;1:15009.
   PubMed Web of Science ®Google Scholar
• Negrini M, Calin GA. Breast cancer metastasis: a microRNA story. Breast Cancer Res. 2008;10(2):203. PubMed PMID: 18373886; PubMed Central PMCID: PMCPMC2397516.
   PubMed Web of Science ®Google Scholar
• Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005 Aug 15;65(16):7065–7070. PubMed PMID: 16103053.
   PubMed Web of Science ®Google Scholar
• Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008 Apr 3;27(15):2128–2136. PubMed PMID: 17968323.
   PubMed Web of Science ®Google Scholar
• Kong W, He L, Richards EJ, et al. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene. 2014 Feb 6;33(6):679–689. PubMed PMID: 23353819; PubMed Central PMCID: PMCPMC3925335.
   PubMed Web of Science ®Google Scholar
• Imam JS, Buddavarapu K, Lee-Chang JS, et al. MicroRNA-185 suppresses tumor growth and progression by targeting the six1 oncogene in human cancers. Oncogene. 2010 Sep 2;29(35):4971–4979. PubMed PMID: 20603620.
   PubMed Web of Science ®Google Scholar
• Dong P, Kaneuchi M, Watari H, et al. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer. 2011 Aug 18;10:99. . PubMed PMID: 21851624; PubMed Central PMCID: PMCPMC3173388.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Zhang Y, Cao R, et al. miR-5195-3p inhibits proliferation and invasion of human bladder cancer cells by directly targeting oncogene KLF5. Oncol Res. 2017 Aug 7;25(7):1081–1087. PubMed PMID: 28109084.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tian H, Miao Y, et al. Upregulation of p72 enhances malignant migration and invasion of glioma cells by repressing beclin1 expression. Biochemistry (Mosc). 2016 Jun;81(6):574–582. PubMed PMID: 27301285.
   PubMed Web of Science ®Google Scholar
• Seiler C, Ben-David O, Sidi S, et al. Myosin VI is required for structural integrity of the apical surface of sensory hair cells in zebrafish. Dev Biol. 2004 Aug 15;272(2):328–338. PubMed PMID: 15282151.
   PubMed Web of Science ®Google Scholar
• Wells AL, Lin AW, Chen LQ, et al. Myosin VI is an actin-based motor that moves backwards. Nature. 1999 Sep 30;401(6752):505–508. PubMed PMID: 10519557.
   PubMed Web of Science ®Google Scholar
• Masters TA, Buss F. Filopodia formation and endosome clustering induced by mutant plus-end-directed myosin VI. Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1595–1600. PubMed PMID: 28143933; PubMed Central PMCID: PMCPMC5320995.
   PubMed Web of Science ®Google Scholar
• You N, Li J, Gong Z, et al. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma. Mol Carcinog. 2016;56(2):607–624.
   Web of Science ®Google Scholar
• Mohiddin SA, Ahmed ZM, Griffith AJ, et al. Novel association of hypertrophic cardiomyopathy, sensorineural deafness, and a mutation in unconventional myosin VI (MYO6). J Med Genet. 2004 Apr;41(4):309–314. PubMed PMID: 15060111; PubMed Central PMCID: PMCPMC1735721.
   PubMed Web of Science ®Google Scholar
• Avraham KB, Hasson T, Sobe T, et al. Characterization of unconventional MYO6, the human homologue of the gene responsible for deafness in Snell’s waltzer mice. Hum Mol Genet. 1997 Aug;6(8):1225–1231. PubMed PMID: 9259267.
   PubMed Web of Science ®Google Scholar
• Dunn TA, Chen S, Faith DA, et al. A novel role of myosin VI in human prostate cancer. Am J Pathol. 2006 Nov;169(5):1843–1854. PubMed PMID: 17071605; PubMed Central PMCID: PMCPMC1780223.
   PubMed Web of Science ®Google Scholar
• Gleason DF, Mellinger GT. Veterans administration cooperative urological research G. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. 1974. J Urol. 2002 Feb;167(2 Pt 2):953–958. discussion 959. PubMed PMID: 11905924.
   PubMed Web of Science ®Google Scholar
• Kay FU, Kandathil A, Batra K, et al. Revisions to the tumor, node, metastasis staging of lung cancer (8(th) edition): rationale, radiologic findings and clinical implications. World J Radiol. 2017 Jun 28;9(6):269–279. PubMed PMID: 28717413; PubMed Central PMCID: PMC5491654.
   PubMed Web of Science ®Google Scholar
• Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med. 2004 Dec;1(3):e65. PubMed PMID: 15630470; PubMed Central PMCID: PMCPMC539051.
   PubMed Web of Science ®Google Scholar
• Sood P, Krek A, Zavolan M, et al. Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2746–2751. PubMed PMID: 16477010; PubMed Central PMCID: PMCPMC1413820.
   PubMed Web of Science ®Google Scholar
• Chapman BV, Wald AI, Akhtar P, et al. MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer. BMC Cancer. 2015 Nov 6;15:861. . PubMed PMID: 26545583; PubMed Central PMCID: PMCPMC4635687.
   PubMed Web of Science ®Google Scholar
• Lei C, Du F, Sun L, et al. miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6. Cell Death Dis. 2017 Oct 12;8(10):e3101. PubMed PMID: 29022908; PubMed Central PMCID: PMC5682659.
   PubMed Web of Science ®Google Scholar
• Wei AW, Li LF. Long non-coding RNA SOX21-AS1 sponges miR-145 to promote the tumorigenesis of colorectal cancer by targeting MYO6. Biomed Pharmacother. 2017 Dec;96:953–959. PubMed PMID: 29217166.
   PubMed Web of Science ®Google Scholar
• Kasinski AL, Kelnar K, Stahlhut C, et al. A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer. Oncogene. 2015 Jul;34(27):3547–3555. PubMed PMID: 25174400; PubMed Central PMCID: PMCPMC4345154.
   PubMed Web of Science ®Google Scholar
• Wang D, Zhu L, Liao M, et al. MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40. Oncol Rep. 2016 Sep;36(3):1285–1292. PubMed PMID: 27431378.
   PubMed Web of Science ®Google Scholar
• Majewski L, Sobczak M, Wasik A, et al. Myosin VI in PC12 cells plays important roles in cell migration and proliferation but not in catecholamine secretion. J Muscle Res Cell Motil. 2011 Dec;32(4–5):291–302. PubMed PMID: 22105702; PubMed Central PMCID: PMCPMC3230755.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang B, Zhu W, et al. Lentivirus-mediated knockdown of myosin VI inhibits cell proliferation of breast cancer cell. Cancer Biother Radiopharm. 2015 Oct;30(8):330–335. PubMed PMID: 26407123.
   PubMed Web of Science ®Google Scholar
• Knudsen B. Migrating with myosin VI. Am J Pathol. 2006 Nov;169(5):1523–1526. PubMed PMID: 17071577; PubMed Central PMCID: PMCPMC1780205.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Cheng W, Hung J, et al. Lessons from border cell migration in the Drosophila ovary: A role for myosin VI in dissemination of human ovarian cancer. Proc Natl Acad Sci U S A. 2004 May 25;101(21):8144–8149. PubMed PMID: 15146066; PubMed Central PMCID: PMCPMC419571.
   PubMed Web of Science ®Google Scholar
• Geisbrecht ER, Montell DJ. Myosin VI is required for E-cadherin-mediated border cell migration. Nat Cell Biol. 2002 Aug;4(8):616–620. PubMed PMID: 12134162.
   PubMed Web of Science ®Google Scholar